Search results
Health Care Roundup: Market Talk
The Wall Street Journal· 3 hours agoNEWSPLUS The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1054 ET...
FDA again delays Drug Supply Chain Security Act enforcement
Becker’s Hospital Review· 17 hours agoThe agency announced the exemption June 12 to offer small dispensers more time "to stabilize their operations and fully implement the enhanced drug distribution security requirements" of the ...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 3 days agoThe FDA approved AstraZeneca’s AZN type-II diabetes (T2D) medicine, Farxiga, for pediatric...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 3 days agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
4th company recalls syringes as FDA evaluates problems
Becker’s Hospital Review· 17 hours agoFDA warns against plastic syringes made in China due to leaking issues, leading to multiple recalls by four companies. Quality problems reported since November.
Joe Grogan: Access to new Alzheimer’s treatments bogged down by Medicare policy
Chicago Tribune· 14 hours agoAlzheimer’s is a progressive, fatal disease that boggled scientists for a century. Now, at last, we...
Supreme Court unanimously rejects challenge to FDA approval of abortion drug mifepristone
United Press International via Yahoo News· 4 days agoThe U.S. Supreme Court Thursday unanimously rejected an effort to make it harder to access the...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 4 days agoIf the FDA approves Lykos’ application in August, it would be the first time in the agency’s history...
Two Is Better Than One in the Alzheimer’s Market
The Wall Street Journal· 13 hours agoLast week, a panel of independent advisers to the FDA unanimously voted in support of Eli Lilly donanemab, a competitor in the same class of drugs that...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 5 days ago"FDA approves AstraZeneca’s Farxiga for paediatric T2D patients" was originally created and...
